References
- Beckwith J B, Palmer N F. Histopathology and prognosis of Wilms tumours: results from the First National Wilms' Tumor Study. Cancer 1978; 41: 1937–1948
- Haas J E, Palmer N F, Weinberg A G, et al. Ultrastructure of malignant rhabdoid tumour of the kidney. A distinctive renal tumour of children. Hum Pathol 1981; 12: 646–657
- Lefkowitz I B, Rorke L B, Packer R J, et al. Atypical teratoma of infancy: definition of an entity. Ann Neurol 1987; 22: 448–449
- Weeks D A, Beckwith J B, Mierau G W, et al. Rhabdoid tumour of the kidney. A report of 111 cases from National Wilms' Tumour Study Pathology Center. Am J Surg Pathol 1989; 13: 439–458
- Rorke L B, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 1995; 24: 21–28
- Rorke L B, Packer R J, Biegel J A. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996; 85: 56–65
- Biegel J A, Rorke L B, Packer R J, et al. Monosomy 22 in rhabdoid or atypical tumours of the brain. J Neurosurg 1990; 73: 710–714
- Parham D M, Weeks D A, Beckwith J B. The clinicopathologic spectrum of putative extrarenal rhabdoid tumours: an analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994; 18: 1010–1029
- Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998; 394: 203–206
- Judkins A R, Mauger J, Rorke L B, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004; 28: 644–650
- Rousseau-Merck M F, Versteege I, Legrand I, et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumours. Cancer Res 1999; 59: 3152–3156
- Biegel J A, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumours. Clin Cancer Res 2002; 8: 3461–3467
- Biegel J A, Zhou J Y, Rorke L B, et al. Germ-line and acquired mutations of INI1in atypical teratoid and rhabdoid tumors. Cancer Res 1999; 59: 74–79
- Ammerlaan A C, Ararou A, Houben M P, et al. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008; 98: 474–479
- Hoot A C, Russo P, Judkins A R, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extrarenal malignant rhabdoid tumors from other paediatric soft tissue tumours. Am J Surg Pathol 2004; 28: 1485–1491
- Kohashi K, Oda Y, Yamamoto H, et al. Highly aggressive behavior of malignant rhabdoid tumour: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol 2007; 133: 817–824
- Uno K, Takita J, Yokomori K, et al. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumours or atypical teratoid/rhabdoid tumours in paediatric solid tumours. Genes Chromosomes Cancer 2002; 34: 33–41
- Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 2005; 65: 4012–4019
- Hornick J L, Dal Cin P, Fletcher C D. Loss of INI1 expression is characteristic of both conventional and proximal-type epitheliod sarcomas. Mod Pathol 2007; 20(Suppl 2)16A
- Gleason B C, Fletcher C D. Myoepithelial carcinomas of soft tissue in children: an aggressive neoplasm analysed in a series of 29 cases. Am J Surg Pathol 2007; 31: 1813–1824
- Perry A, Fuller C E, Judkins A R, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 2005; 18: 951–958
- Hulsebos T J, Plomp A S, Wolterman R A, et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007; 80: 805–810
- Biegel J A, Fogelgren B, Zhou J Y, et al. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumours of the central nervous system. Clin Cancer Res 2000; 6: 2759–2763
- Judkins A R, Burger P C, Hamilton R L, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumour from choroid plexus carcinoma. J Neuropathol Exp Neurol 2005; 64: 391–397
- Haberler C, Laggner U, Slavc I, et al. Immunohistochemical analysis of INI1 protein in malignant paediatric CNS tumours: lack of INI1 in atypical teratoid/rhabdoid tumours and in a fraction of primitive neuroectodermal tumours without rhabdoid phenotype. Am J Surg Pathol 2006; 30: 1462–1468
- Waldron P E, Rodgers B M, Kelly M D, et al. Successful treatment of a patient with stage IV rhabdoid tumour of the kidney: case report and review. J Pediatr Hematol Oncol 1999; 21: 53–57
- Wagner L, Hill D A, Fuller C, et al. Treatment of metastatic rhabdoid tumour of the kidney. J Pediatr Hematol Oncol 2002; 24: 385–388